Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | HTR1D | P28221 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | HTR1B | P28222 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8536110 | 0.77 | CYP2D6 (0.36) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL1086377 | 0.71 | POLB (0.52) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL914375 | 0.71 | CYP2C19 (0.40) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL7904051 | 0.70 | CYP2D6 (0.36) | CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL4589689 | 0.70 | CYP2D6 (0.54) | CYP2C19CYP1A2CYP2D6HIF1A | |
| SCHEMBL916519 | 0.69 | CYP2D6 (0.39) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL914352 | 0.68 | CYP2C19 (0.38) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL6940383 | 0.68 | PTGDR2 (0.42) | — | |
| SCHEMBL914908 | 0.67 | PTPN1 (0.42) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL9127939 | 0.66 | CYP2D6 (0.31) | CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5516777-A | PROSTATE CANCER THERAPY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1996-05-14 | — | — | US | disclosed |
| US-5409928-A | Prostate diseases, alopecia | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-04-25 | — | — | US | disclosed |
| EP-0594149-A2 | Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-04-27 | — | — | EP | disclosed |